Morgan Stanley Rates Cerebras Systems (CBRS) buy

Morgan Stanley analyst Joseph Moore maintains a buy rating on Cerebras Systems with a $273 price target, a 58.89% upside from the current price.

Reviewed by automated data checks against the source data. How we make and check alerts

Morgan Stanley rated Cerebras Systems Inc. ($CBRS) "buy" with a $273 price target on June 24, 2026.

Since the rating, $CBRS is up 21.4% after 1 week, up 9.2% after 1 month and down 30.2% to date (from the $182.26 close on Jun 24, 2026).

CBRS Cerebras Systems Inc.
$127.21 -29.51% past 3 months
Daily close · Oct 16, 2026

Key Points

  • Morgan Stanley analyst Joseph Moore reiterated a buy rating on Cerebras Systems Inc. (NasdaqGS: CBRS) with a $273 price target on June 24, 2026.
  • Morgan Stanley's $273 price target implies 58.89% upside from Cerebras Systems Inc.'s ($CBRS) current $171.82 share price.
  • Cerebras Systems shares traded at $171.82 on Wednesday, sitting between its 52-week low of $133.88 and high of $386.34.
  • Wall Street maintains a general consensus recommendation of strong buy for the semiconductor company, backed by 11 analyst opinions and a mean target price of $291.64.

Get $CBRS trade alerts by text

We text you when insiders, Congress or big funds trade $CBRS. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated Cerebras Systems Inc. alert may contain errors. Disclosures

Morgan Stanley Reaffirms Buy Rating on Cerebras Systems

Morgan Stanley has reaffirmed its positive stance on Cerebras Systems Inc. (NasdaqGS: CBRS). On June 24, 2026, analyst Joseph Moore reiterated a buy rating on the artificial intelligence infrastructure company while setting a price target of $273. The update keeps the firm's outlook steady as the semiconductor maker navigates market shifts.

Analyst rating track record

Morgan Stanley vs. the S&P 500

YTD return +29.22% hypothetical
All-time return +25.85% S&P 500 +32.69%
vs. S&P 500 -6.84% behind the index

Hypothetical returns from Morgan Stanley's disclosed trades, not real profit or advice. How we model this.

Cerebras Systems Stock Trades Below Moving Averages

Shares of Cerebras Systems changed hands at $171.82 on Wednesday. The stock trades well below its 50-day moving average of $195.14 and its 200-day moving average of $207.91. Over the past year, the shares have moved between a low of $133.88 and a high of $386.34. The company carries a market capitalization of roughly $33.77 billion and has a forward price-to-earnings ratio of 111.62.

12-month forecast

$CBRS price target

Cerebras Systems Inc. daily closes and this analyst's $273 target. Not advice.

Wall Street Analyst Outlook and Price Targets

Other research firms have also recently updated their views on Cerebras Systems. On October 2, 2026, Freedom Capital Markets upgraded the stock to a buy with a $209 price target, following an earlier hold rating on September 14, 2026. Rosenblatt and Needham both maintained buy ratings and $300 price targets on August 19, 2026. Earlier in August, UBS maintained a buy rating while lifting its target to $330 from $320, and Citigroup maintained a buy rating while trimming its target to $320 from $340. Wedbush and Mizuho also kept outperform ratings in August with targets of $290 and $300, respectively. Across 11 analyst opinions, the stock holds a consensus recommendation of strong buy, with a mean price target of $291.64, a high target of $330, and a low target of $209.

What Cerebras Systems Does

Cerebras Systems Inc. operates as an artificial intelligence infrastructure company based in Sunnyvale, California. The company designs and manufactures an AI compute platform that includes proprietary systems and software delivered in racks for data centers. Its core innovation is a wafer-scale engine, which is a chip encompassing an entire silicon wafer built to handle the heavy computational demands of inference and generative AI.

Looking Ahead for Cerebras Systems

Investors will look toward the company's next earnings report, scheduled for November 10, 2026, for further details on revenue and margins. The company posted annual revenue of $680.67 million with a revenue growth rate of 74.3%, alongside an EPS of -$5.14.

Source: Morgan Stanley's rating change on $CBRS (Jun 24, 2026). Written by software, not financial advice. How we make alerts

Get $CBRS trade alerts by text